Clinical Characteristics and Discharge Assessment of Patients From Palliative Care
NCT ID: NCT04755374
Last Updated: 2021-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
103 participants
OBSERVATIONAL
2021-02-20
2021-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care
NCT02814682
Palliative Outcome Evaluation Muenster I
NCT03286127
Evaluation of Preoperative Acceptance of Proactive Palliative Care Intervention
NCT05575791
Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease
NCT02175147
Identification of Obstacles and Levers to Interdisciplinary Work in Palliative Care Units
NCT06208644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patient's age, gender, diagnosis, conditions/comorbidities, Karnofsky Performance Scale, discharge status (death, intensive care unit or at home), gastrostomy status, presence of tracheostomy and/or mechanical ventilation, nutritional status (total parenteral nutrition or enteral nutrition), pressure ulcers, the lowest and highest recorded hemoglobin concentration, white blood cell count and serum sodium concentration and the education level of the patient and the caregiver will be recorded. Patients will be grouped according to length of stay (LOS) as Group 1: discharged in equal or less than 21 days or Group 2: Prolonged discharged in longer than 21 days and analysed accordingly
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Discharged from palliative care unit in equal or less than 21 days
Discharged ≤ 21 days
Discharged from palliative care unit in equal less than 21 days
Group 2: Prolonged discharged in longer than 21 days
Discharged from palliative care unit in longer than 21 days
Prolonged discharge
Discharged from palliative care unit in longer than 21 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Discharged ≤ 21 days
Discharged from palliative care unit in equal less than 21 days
Prolonged discharge
Discharged from palliative care unit in longer than 21 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diskapi Yildirim Beyazit Education and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gulten Utebey
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gulten Utebey, Dr
Role: PRINCIPAL_INVESTIGATOR
Ministry of Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diskapi Yildirim Beyazit Teaching and Research Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gomes B, Higginson IJ. Where people die (1974--2030): past trends, future projections and implications for care. Palliat Med. 2008 Jan;22(1):33-41. doi: 10.1177/0269216307084606.
Lau F, Downing GM, Lesperance M, Shaw J, Kuziemsky C. Use of Palliative Performance Scale in end-of-life prognostication. J Palliat Med. 2006 Oct;9(5):1066-75. doi: 10.1089/jpm.2006.9.1066.
Kelly A, Conell-Price J, Covinsky K, Cenzer IS, Chang A, Boscardin WJ, Smith AK. Length of stay for older adults residing in nursing homes at the end of life. J Am Geriatr Soc. 2010 Sep;58(9):1701-6. doi: 10.1111/j.1532-5415.2010.03005.x. Epub 2010 Aug 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Palliative-Discharge
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.